- Case Report
- Open Access
Atypical adenomatous hyperplasia (adenosis) of the prostate: a case report with review of the literature
© Armah and Parwani; licensee BioMed Central Ltd. 2008
- Received: 07 August 2008
- Accepted: 12 August 2008
- Published: 12 August 2008
A 62-year-old male presented with symptoms of urinary obstruction and elevated serum prostate-specific antigen level of 3.61 ng/mL. Prostate needle biopsies showed benign prostatic tissue with a focus of crowded glands with minimal cytological atypia, fairly well-circumscribed with infiltrative appearance of glands at the edges. This focus had both small and larger glands with similar histological features. This focus was strongly positive for alpha-methylacyl-coenzyme A-racemase (AMACR), but showed scattered patchy staining with basal cell markers (p63 and CK903/34βE12). Hence, the final histologic diagnosis was benign prostatic tissue with a focus of florid adenosis. Two subsequent follow-up prostate needle biopsies performed six and 12 months later both showed benign prostatic tissue with atrophic changes. This case highlights the utility of these three immunostains (AMACR, p63 and CK903/34βE12) in the accurate diagnosis of adenosis of the prostate on needle biopsy, and avoiding its misinterpretation as prostate adenocarcinoma.
- Needle Biopsy
- Prostate Adenocarcinoma
- Prostatic Intraepithelial Neoplasia
- Atypical Adenomatous Hyperplasia
- Needle Biopsy Specimen
Atypical adenomatous hyperplasia (AAH) or adenosis of the prostate is a pseudoneoplastic lesion that can mimic prostate adenocarcinoma because of its cytologic and architectural features [1–3]. For many years, atypical epithelial lesions of the prostate have been known to occur, but much refining of this knowledge has evolved over the last two decades. Initially two lesions, prostatic intraepithelial neoplasia (PIN) and AAH, were assumed to be precursors of prostatic adenocarcinoma [1–3]. However, PIN now remains as the only well-proven preneoplastic condition with clinical significance. AAH is no longer considered a premalignant lesion but rather a benign small glandular process of the transition zone that simulates acinar adenocarcinoma [1–3]. Since AAH occurs predominantly in the transition zone, which is only rarely sampled in needle biopsy, it is uncommon to see examples of this lesion in biopsy specimens. However, as the sampling of the transition zone of the prostate has become more frequent recently with ultrasound-guided multiple segmental prostate biopsies  the practicing surgical pathologists must be aware of the histologic features of AAH of the prostate in needle biopsy specimens, in order to avoid misinterpretation of AAH of the prostate, a benign lesion, as prostate adenocarcinoma. Additionally, because some patients showing raised prostate specific antigen levels and negative peripheral zone biopsy may present with transition zone prostatic adenocarcinoma, sampling of the transition zone of the prostate by needle biopsy and the identification of AAH are likely to increase .
A 62-year-old male was referred to his urologist for symptoms of urinary obstruction and an elevated serum prostate-specific antigen (PSA) level of 3.61 ng/mL. Digital rectal examination and ultrasound revealed an ill-defined nodule in the prostate suggestive of malignancy. A needle biopsy was performed.
The final histologic diagnosis was benign prostatic tissue with a focus of florid AAH. Two subsequent follow-up prostate needle biopsies performed six and 12 months later both showed benign prostatic tissue with atrophic changes.
AAH of the prostate is a microglandular lesion and a recognized mimicker of small acinar adenocarcinoma [1–3]. AAH is characterized by a proliferation of prostatic glands with abnormal architectural patterns, but without significant cytologic atypia. AAH of the prostate is usually an incidental finding in transurethral resections or simple prostatectomies performed in the clinical setting of benign prostatic hyperplasia. The prevalence of AAH in transurethral prostatectomy specimens without cancer ranges from 1.6% to 7.3%  compared to its prevalence of 0.8% in needle biopsy specimens . Their rarity in needle biopsies of the prostate is attributable to the fact that sampling of the transition zone is not common in needle biopsies. Although, AAH can be diagnosed throughout the prostate, it is most often located in the transition zone of the prostate in intimate association with benign nodular hyperplasia . Since the frequency of needle biopsies, including tissue from the transition zone, is likely to increase due to the introduction of ultrasound-guided multiple segmental prostate biopsy , knowledge of the main diagnostic histologic features of AAH would represent an important issue in genitourinary surgical pathology. The diagnosis of AAH in needle biopsies, as seen in the case herein presented, relies on both histologic features in hematoxylin and eosin-stained slides and immunohistochemical features.
Microscopically, AAH is a localized proliferative lesion consisting of small amounts of atypical epithelial cells arranged in irregular glandular patterns, often within or adjacent to typical hyperplastic nodules . At low magnification, it is usually partially circumscribed with a pushing rather than infiltrating border, although the small acini may show a limited degree of infiltrative features at the margins. The individual glands are closely packed but separate and show no evidence of fusion. The glands show some variation in size and shape and are lined by cuboidal to low columnar cells with moderate to abundant clear or lightly eosinophilic cytoplasm [6, 9]. The basal cells are usually recognized at least focally. The luminal borders are often irregular and somewhat serrated in contrast to the rigid borders that typify small acinar carcinoma. The lumens are often empty but may contain corpora amylacea and in some instances luminal eosinophilic crystalloids [5, 9]. The nuclei are round to oval, slightly enlarged, and with uniform fine chromatin and inconspicuous or small nucleoli . AAH can be difficult to distinguish from low-grade prostatic adenocarcinoma (Gleason pattern 1 or 2) because both are located in the transition zone and show small acinar proliferation and intraluminal crystalloids . The two distinguishing features of AAH are the lack of significant cytological atypia and the presence of patchy basal cells, which can be demonstrated by patchy immunostaining for high molecular-weight cytokeratin (CK903/34βE12) or p63 [7–9]. In contrast, prostatic adenocarcinoma usually shows notable nuclear atypia, lacks basal cells, and rarely expresses high molecular weight cytokeratin . Yang and colleagues  found that AMACR was focally expressed in 10% of cases and diffusely positive in only 7.5% of cases of AAH. The biological significance of AMACR expression in a small subset of AAH remains to be determined. AAH differs from sclerosing adenosis, another benign mimicker of prostate adenocarcinoma, since sclerosing adenosis displays myoepithelial features of the basal cells and an exuberant stroma of fibroblasts and loose ground substance .
While circumstantial evidence exists, there is lack of proof of a relationship between AAH and adenocarcinoma. It has been suggested that AAH is a precursor of some low-grade transition zone carcinomas but the lack of an increased prevalence of AAH in prostate glands with transition zone carcinoma argues against this hypothesis. Clearly, there is less evidence linking AAH to carcinoma than there is for high-grade PIN and cancer. Therefore, the major importance of AAH is its potential for being misdiagnosed as adenocarcinoma. Biochemical and molecular analyses of AAH have generated inconclusive results. There is limited data that AAH has a proliferation rate higher than hyperplasia but lower than adenocarcinoma [1, 7, 8, 13]. By the use of fluorescent in situ hybridization analysis, chromosomal anomalies were seen in only 9% of AAH cases, compared with 55% of prostatic adenocarcinoma cases . Two independent studies showed that AAH contains genetic alterations commonly found in early prostatic carcinoma, with changes being reported in 47% or 12% of AAH cases, respectively [8, 14]. Recent cytogenetic analyses have detected abnormalities of chromosome 8 in a very small proportion (4–7%) of AAH cases [7, 8]. The recent finding of molecular alterations in AAH including immunoreactivity for AMACR, a marker linked to prostate adenocarcinoma, suggests that at least a subset of AAH cases might be related to prostate carcinoma of the transition zone [11, 13, 14].
The widespread use of PSA screening has led to an increase in prostate needle biopsies and, subsequently, an increase in earlier detection of prostate carcinoma. This trend has also led to an increase in the number of equivocal diagnoses on prostate biopsy specimens. Surgical pathologists must make critical decisions on an increasing number of prostate needle biopsy specimens with only small foci of atypical glands. In this setting, the mimics of prostate cancer must be distinguished from a small focus of adenocarcinoma. The distinction of benign small acinar proliferations (benign mimickers of cancer) from atypical acinar proliferations suspicious for cancer is crucial, since the subsequent clinical approach is different. Biopsies harboring a small focus of atypical glands frequently represent an under-sampled cancer and a subsequent biopsy will show cancer in up to 50% of cases . In contrast, following a diagnosis of benign mimickers of cancer (such as atrophy or AAH), a re-biopsy is usually not indicated.
AAH is a transition zone lesion of the prostate that can simulate small acinar carcinoma. By itself positive immunostaining for AMACR is not diagnostic for carcinoma because the latter is also positive in high-grade PIN and some benign mimickers of adenocarcinoma. The case herein presented highlights the utility of AMACR, p63 and CK903/34βE12 immunostaining in the accurate diagnosis of adenosis of the prostate, a benign mimicker of prostate adenocarcinoma.
Consent was received from the patient before publication.
- Helpap B: The biological significance of atypical hyperplasia of the prostate. Virchows Arch A Pathol Anat Histol. 1980, 387 (3): 307-317. 10.1007/BF00454834.View ArticlePubMedGoogle Scholar
- Helpap BG, Bostwick DG, Montironi R: The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma. An update. Virchows Arch. 1995, 426 (5): 425-434. 10.1007/BF00193163.View ArticlePubMedGoogle Scholar
- Helpap B, Bonkhoff H, Cockett A, Montironi R, Troncoso P, Waters D, Bostwick D: Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma. Pathologica. 1997, 89 (3): 288-300.PubMedGoogle Scholar
- Liu IJ, Macy M, Lai YH, Terris MK: Critical evaluation of the current indications for transition zone biopsies. Urology. 2001, 57 (6): 1117-1120. 10.1016/S0090-4295(01)00944-X.View ArticlePubMedGoogle Scholar
- Gaudin PB, Epstein JI: Adenosis of the prostate. Histologic features in transurethral resection specimens. Am J Surg Pathol. 1994, 18 (9): 863-870.View ArticlePubMedGoogle Scholar
- Gaudin PB, Epstein JI: Adenosis of the prostate. Histologic features in needle biopsy specimens. Am J Surg Pathol. 1995, 19 (7): 737-747.View ArticlePubMedGoogle Scholar
- Bostwick DG, Qian J: Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies. Am J Surg Pathol. 1995, 19 (5): 506-518.View ArticlePubMedGoogle Scholar
- Cheng L, Shan A, Cheville JC, Qian J, Bostwick DG: Atypical adenomatous hyperplasia of the prostate: a premalignant lesion?. Cancer Res. 1998, 58 (3): 389-391.PubMedGoogle Scholar
- Bostwick DG, Srigley J, Grignon D, Maksem J, Humphrey P, van der Kwast TH, Bose D, Harrison J, Young RH: Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol. 1993, 24 (8): 819-832. 10.1016/0046-8177(93)90131-Y.View ArticlePubMedGoogle Scholar
- Buhmeida A, Pyrhonen S, Laato M, Collan Y: Prognostic factors in prostate cancer. Diagn Pathol. 2006, 1: 4-10.1186/1746-1596-1-4.PubMed CentralView ArticlePubMedGoogle Scholar
- Yang XJ, Wu CL, Woda BA, Dresser K, Tretiakova M, Fanger GR, Jiang Z: Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol. 2002, 26 (7): 921-925. 10.1097/00000478-200207000-00011.View ArticlePubMedGoogle Scholar
- Hansel DE, Herawi M, Montgomery E, Epstein JI: Spindle cell lesions of the adult prostate. Mod Pathol. 2007, 20 (1): 148-158. 10.1038/modpathol.3800676.View ArticlePubMedGoogle Scholar
- Qian J, Jenkins RB, Bostwick DG: Chromosomal anomalies in atypical adenomatous hyperplasia and carcinoma of the prostate using fluorescence in situ hybridization. Urology. 1995, 46 (6): 837-842. 10.1016/S0090-4295(99)80354-9.View ArticlePubMedGoogle Scholar
- Doll JA, Zhu X, Furman J, Kaleem Z, Torres C, Humphrey PA, Donis-Keller H: Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis). Am J Pathol. 1999, 155 (3): 967-971.PubMed CentralView ArticlePubMedGoogle Scholar
- Chan TY, Epstein JI: Follow-up of atypical prostate needle biopsies suspicious for cancer. Urology. 1999, 53 (2): 351-355. 10.1016/S0090-4295(98)00510-X.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.